Shehla Adhami

Shehla Adhami

Auto-generated profile, based on publicly available information

Shehla Adhami

Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi, 110062, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2021 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SAShehla Adhami
Shehla Adhami
HFHumaira Farooqi
Humaira Farooqi
MAMalik Zainul Abdin
Malik Zainul Abdin
Ram PrasadRam Prasad
Ram Prasad
AMAsrar A. Malik
Asrar A. Malik
Background: Chlorophytum comosum popularly known as Spider Ivy is used as medicinal plant in traditional Chinese medicine, however its detailed chemical composition and biological activity is yet unexplored. Objective: To carry out phytochemical investigation on different parts of Chlorophytum comosum using GC-MS/LC-ESI-MS and evaluation of its antioxidant, haemolytic and antiproliferative potential on breast cancer (MCF-7), lung cancer (A549, H1299) and normal lung (L-132) cell lines. Methods: Chemical constituents from aqueous roots and leaves extracts were identified using LC-ESI-MS/GC-MS. The identified compounds were annotated based on match of mass spectra with the literature using NIST 14 and METLIN databases. Antioxidant activity was checked using DPPH, FRAP and TPC assays. The antiproliferative effects of ethanolic roots and leaves extracts of Chlorophytum comosum were measured by MTT assay on breast cancer (MCF-7), lung cancer (A549 & H1299) and normal lung (L-132) cell lines. The toxicity studies of the extracts were carried out using Haemolysis assay. Results: GC-MS analysis identified 34 metabolites in roots and 17 from leaves, while as 17 compounds from roots and 7 from leaves were detected by LC-ESI-MS. Significant antiproliferative effects were observed on the A549 and MCF-7 cancer cell lines with IC50 values ranging from 56.86 µg/ml to 68.68 µg/ml while no marked response was observed against normal cell line L-132. Conclusion: Our study represents the first report on the detailed chemical composition and antiproliferative potential of Chlorophytum comosum against lung and breast cancer cell lines.

29 January 2025 in Research Square
Verified
Preprint
Open access
PDF file
SAShehla Adhami
Shehla Adhami
HFHumaira Farooqi
Humaira Farooqi
AMAsrar Ahmad Malik
Asrar Ahmad Malik
Methods The ethanolic roots (CCRE) and leaves (CCLE) extracts were interrogated for their apoptotic potential against human lung adenocarcinoma cell line (A549) using DNA fragmentation, Annexin V-FITC/PI staining apoptosis assay and cell cycle analysis using flow cytometry. Results Our results revealed significant DNA damage and apoptosis induced cell death in A549 cell line on treatment with active concentrations (40 µg/ml and 80 µg/ml) of the ethanolic extracts with S phase cell cycle arrest. Conclusions This is the first study demonstrating the apoptosis inducing potential of chemically characterized bioactive compounds present in ethanolic leaves and roots extracts from Chlorophytum comosum against non-small cell human lung adenocarcinoma cell line. The study concludes that Chlorophytum comosum can be a potential candidate for the natural bioactive compounds that can be isolated, characterized and clinically evaluated for the development of novel naturally derived anti-cancer drugs against lung cancer.

21 October 2026 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SAShehla Adhami
Shehla Adhami
HFHumaira Farooqi
Humaira Farooqi
Natural products derived from plants, animals, microbes, and minerals remain a cornerstone of modern drug discovery by virtue of their structural-functional diversity and broad spectrum of bioactivities. However, the isolation and characterization of bioactive compounds from complex natural matrices remain a significant challenge in conventional methodologies, primarily due to metabolites’ anonymity, low metabolite abundance, chemical instability, dereplication of already known metabolites, time-consuming processes, limited resolution, and the complexity and non-ecofriendly nature of many methods. Recent advancements in biotechnological applications, including high-throughput screening platforms and advanced mass spectrometric techniques such as GC-MS, LC-MS, multidimensional 1D, 2D & 3D NMR, metabolomics-driven chemical profiling, rapid DNA-detection-based plant authentication techniques, green extraction technologies, bioanalytical techniques like biochips, probes, biosensors, immunoassays, and tools corresponding to genome mining and network pharmacology areas have significantly accelerated the identification, isolation, and characterization of lead compounds. However, despite these advancements, biotechnological approaches still present critical limitations and challenges involving low metabolite annotation rates, difficulty distinguishing stereoisomers, and limited reproducibility and scalability of extraction processes. The present review critically examines traditional and some selective modern biotechnological strategies employed in natural product isolation and characterization, highlighting their advantages, limitations, and applicability in Pharmacognosy research. Furthermore, it discusses current bottlenecks and emerging integrative approaches aimed at improving efficiency, accuracy, and translational potential in natural products-driven drug discovery.